Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells help improve wound healing by reducing inflammation and promoting skin cell growth and movement.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Msx and Dlx genes are crucial for development, controlling cell behaviors like growth and differentiation through their roles as gene regulators.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

JAK inhibitors show promise for treating various skin diseases.

Herbal compounds might help hair growth, but more testing is needed.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Stem cell therapy shows promise for better burn healing but needs more research and standardization.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Abnormal ECM and immune cell interactions can cause skin diseases.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Stem-cell therapy shows promise for skin conditions but needs more research.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Exosomes show promise for healing diabetic foot ulcers.